BIB vs. IZRL ETF Comparison
Comparison of ProShares Ultra Nasdaq Biotechnology (BIB) to ARK Israel Innovative Technology ETF (IZRL)
BIB
ProShares Ultra Nasdaq Biotechnology
BIB Description
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$61.70
Average Daily Volume
18,871
Number of Holdings
*
200
* may have additional holdings in another (foreign) market
IZRL
ARK Israel Innovative Technology ETF
IZRL Description
The ARK Israel Innovative Technology ETF (IZRL) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index includes equity securities and depositary receipts of exchange listed companies that are incorporated and/or domiciled in Israel (‘‘Israeli Companies’’) and are included in one of the following economic sectors as defined by FactSet Research Systems: (i) health technology, (ii) communications, (iii) technology services, (iv) electronic technology, (v) consumer services, or (vi) producer manufacturing.Grade (RS Rating)
Last Trade
$19.33
Average Daily Volume
13,169
Number of Holdings
*
24
* may have additional holdings in another (foreign) market
Performance
| Period | BIB | IZRL |
|---|---|---|
| 30 Days | 8.88% | -4.57% |
| 60 Days | 24.24% | -0.39% |
| 90 Days | 6.21% | -7.88% |
| 12 Months | 17.80% | 4.46% |
1 Overlapping Holdings
| Symbol | Grade | Weight in BIB | Weight in IZRL | Overlap | |
|---|---|---|---|---|---|
| URGN | B | 0.04% | 2.62% | 0.04% |
BIB Overweight 199 Positions Relative to IZRL
| Symbol | Grade | Weight | |
|---|---|---|---|
| VRTX | B | 5.98% | |
| AMGN | B | 5.88% | |
| REGN | A | 5.75% | |
| GILD | C | 4.74% | |
| MRNA | C | 3.57% | |
| AZN | A | 3.13% | |
| BIIB | C | 2.23% | |
| ALNY | A | 1.34% | |
| ILMN | D | 1.18% | |
| BMRN | C | 1.09% | |
| UTHR | A | 0.95% | |
| INCY | B | 0.95% | |
| NBIX | C | 0.91% | |
| SNY | B | 0.88% | |
| MEDP | B | 0.83% | |
| RPRX | D | 0.81% | |
| VTRS | D | 0.81% | |
| ARGX | B | 0.8% | |
| SRPT | B | 0.74% | |
| INSM | A | 0.65% | |
| BNTX | F | 0.58% | |
| PCVX | B | 0.53% | |
| ASND | C | 0.49% | |
| JAZZ | F | 0.48% | |
| EXEL | B | 0.45% | |
| BGNE | D | 0.45% | |
| ITCI | B | 0.45% | |
| HALO | A | 0.43% | |
| BPMC | B | 0.43% | |
| RVMD | B | 0.41% | |
| IONS | B | 0.4% | |
| SMMT | B | 0.38% | |
| CYTK | F | 0.37% | |
| MDGL | B | 0.37% | |
| CRSP | D | 0.34% | |
| KRYS | B | 0.34% | |
| APLS | F | 0.33% | |
| BBIO | F | 0.32% | |
| NUVL | B | 0.31% | |
| ALKS | D | 0.28% | |
| IMVT | D | 0.26% | |
| GH | C | 0.25% | |
| AXSM | B | 0.24% | |
| MRUS | B | 0.22% | |
| RARE | F | 0.22% | |
| LEGN | D | 0.22% | |
| ARWR | C | 0.21% | |
| CRNX | D | 0.21% | |
| RNA | B | 0.21% | |
| FOLD | D | 0.2% | |
| XENE | F | 0.19% | |
| IDYA | D | 0.19% | |
| TWST | C | 0.19% | |
| ACLX | C | 0.19% | |
| DNLI | B | 0.19% | |
| SWTX | F | 0.18% | |
| PTCT | C | 0.18% | |
| ACAD | D | 0.17% | |
| RYTM | B | 0.17% | |
| GERN | C | 0.17% | |
| DYN | B | 0.17% | |
| ADMA | B | 0.16% | |
| AGIO | B | 0.16% | |
| NTLA | C | 0.16% | |
| MYGN | B | 0.15% | |
| IOVA | D | 0.15% | |
| VCEL | C | 0.14% | |
| JANX | D | 0.14% | |
| NVCR | C | 0.14% | |
| RXRX | C | 0.14% | |
| FTRE | F | 0.14% | |
| VERA | D | 0.13% | |
| PTGX | C | 0.13% | |
| RCKT | C | 0.13% | |
| KYMR | D | 0.13% | |
| AMPH | D | 0.13% | |
| BEAM | C | 0.13% | |
| NVAX | C | 0.13% | |
| ARVN | F | 0.12% | |
| KURA | C | 0.11% | |
| KROS | F | 0.11% | |
| VCYT | C | 0.11% | |
| EWTX | C | 0.11% | |
| HRMY | C | 0.11% | |
| SNDX | D | 0.11% | |
| SUPN | F | 0.1% | |
| LGND | C | 0.1% | |
| ARDX | F | 0.1% | |
| DVAX | F | 0.1% | |
| MIRM | B | 0.1% | |
| PCRX | D | 0.09% | |
| IMCR | F | 0.09% | |
| MNKD | B | 0.09% | |
| BCRX | C | 0.09% | |
| AKRO | C | 0.09% | |
| ANIP | C | 0.09% | |
| MORF | C | 0.09% | |
| SANA | F | 0.09% | |
| VRNA | C | 0.08% | |
| FDMT | D | 0.08% | |
| XNCR | F | 0.08% | |
| VIR | F | 0.08% | |
| TARS | D | 0.07% | |
| COLL | D | 0.07% | |
| INVA | B | 0.07% | |
| DAWN | D | 0.07% | |
| GMAB | F | 0.07% | |
| IRON | C | 0.07% | |
| PRTA | F | 0.07% | |
| CGEM | D | 0.06% | |
| ETNB | F | 0.06% | |
| GRFS | C | 0.06% | |
| ELVN | C | 0.06% | |
| IRWD | F | 0.06% | |
| ABCL | F | 0.06% | |
| COGT | C | 0.06% | |
| RLAY | D | 0.06% | |
| ZLAB | C | 0.06% | |
| MRVI | F | 0.06% | |
| PHAT | C | 0.05% | |
| PLRX | F | 0.05% | |
| SAGE | F | 0.05% | |
| WVE | D | 0.05% | |
| PRME | D | 0.05% | |
| KNSA | C | 0.05% | |
| NRIX | B | 0.05% | |
| ARCT | F | 0.05% | |
| TSHA | C | 0.05% | |
| ARQT | C | 0.05% | |
| CVAC | D | 0.05% | |
| BCYC | F | 0.05% | |
| AUPH | C | 0.05% | |
| SPRY | D | 0.05% | |
| RGNX | F | 0.04% | |
| THRD | C | 0.04% | |
| SVRA | F | 0.04% | |
| CNTA | C | 0.04% | |
| ITOS | C | 0.04% | |
| LYEL | F | 0.04% | |
| HCM | D | 0.04% | |
| TVTX | C | 0.04% | |
| ZNTL | F | 0.04% | |
| OCUL | C | 0.04% | |
| AUTL | F | 0.04% | |
| HROW | B | 0.04% | |
| EOLS | F | 0.04% | |
| ANAB | B | 0.04% | |
| CSTL | D | 0.04% | |
| SRRK | F | 0.04% | |
| HUMA | C | 0.04% | |
| PETQ | B | 0.04% | |
| OLMA | C | 0.04% | |
| ALLO | F | 0.03% | |
| CABA | F | 0.03% | |
| ACIU | C | 0.03% | |
| PGEN | B | 0.03% | |
| EDIT | F | 0.03% | |
| LXRX | C | 0.03% | |
| TBPH | F | 0.03% | |
| FULC | F | 0.03% | |
| ALEC | F | 0.03% | |
| EYPT | F | 0.03% | |
| VERV | F | 0.03% | |
| PACB | F | 0.03% | |
| VYGR | D | 0.03% | |
| ADPT | C | 0.03% | |
| SIGA | C | 0.03% | |
| REPL | C | 0.03% | |
| KALV | C | 0.03% | |
| TERN | C | 0.03% | |
| OABI | F | 0.03% | |
| ORIC | F | 0.03% | |
| MLYS | D | 0.03% | |
| GLPG | F | 0.03% | |
| ABUS | C | 0.03% | |
| YMAB | D | 0.03% | |
| ATAI | D | 0.02% | |
| QURE | F | 0.02% | |
| RVNC | F | 0.02% | |
| MGNX | F | 0.02% | |
| MGTX | F | 0.02% | |
| AMRN | F | 0.02% | |
| XERS | C | 0.02% | |
| ERAS | F | 0.02% | |
| AVXL | D | 0.02% | |
| PAHC | B | 0.02% | |
| VNDA | B | 0.02% | |
| ALXO | F | 0.02% | |
| MRNS | D | 0.01% | |
| ACRS | C | 0.01% | |
| RAPT | F | 0.01% | |
| ME | F | 0.01% | |
| CRBU | F | 0.01% | |
| VTYX | F | 0.01% | |
| BLUE | F | 0.01% | |
| BMEA | F | 0.01% | |
| CHRS | F | 0.01% | |
| RPHM | F | 0.0% | |
| OVID | F | 0.0% |
BIB Underweight 23 Positions Relative to IZRL
| Symbol | Grade | Weight | |
|---|---|---|---|
| WKME | A | -3.58% | |
| WIX | C | -2.69% | |
| TEVA | B | -2.66% | |
| RSKD | A | -2.56% | |
| CGNT | C | -2.47% | |
| MNDY | C | -2.46% | |
| PLTK | D | -2.46% | |
| CLBT | B | -2.42% | |
| SPNS | B | -2.29% | |
| FVRR | D | -2.27% | |
| CYBR | B | -2.2% | |
| RDWR | D | -2.18% | |
| ITRN | D | -2.17% | |
| INMD | F | -2.15% | |
| SMWB | C | -2.11% | |
| TARO | B | -2.07% | |
| CHKP | B | -2.03% | |
| AUDC | D | -1.91% | |
| MGIC | F | -1.9% | |
| FROG | C | -1.82% | |
| SSYS | F | -1.69% | |
| NNOX | F | -1.69% | |
| NICE | F | -1.49% |
BIB: Top Represented Industries & Keywords
IZRL: Top Represented Industries & Keywords
Industries:
Software - Application
Software - Infrastructure
Communication Equipment
Drug Manufacturers - Specialty & Generic
Medical Devices
Biotechnology
Business Services
Computer Systems
Electronic Gaming & Multimedia
Internet Content & Information
Internet Content & Information
Keywords:
Computing
Systems Integrator
Computer Security
Medicine
Security Solution
Cybersecurity
Information Technology Management
Software
Active Pharmaceutical Ingredients
Artificial Intelligence
Business Intelligence
Cancer
Computer Network Security
Digital Marketing
Firewall Software
Insurance
Law Enforcement
Medication
Pharmaceutical
Pharmaceutical Industries
Compare ETFs
